Gleevec generic name is imatinib mesylate tablets, during the period of taking platelets are likely to be reduced all the time, belongs to a kind of adverse drug reaction, need to be combined with other drugs taken together. Imatinib mesylate tablets is a kind of anticancer drugs, can be used for the treatment of chronic granulocytic leukemia, during the treatment, may cause platelet decline and white blood cell decline and other adverse reactions. Therefore, the continuous decrease of platelet during taking Imatinib Mesylate Tablet is generally normal, and can be relieved by reducing the drug dose under the guidance of specialized doctors. The common adverse reactions of Imatinib Mesylate Tablets include nausea, vomiting, dizziness and tinnitus, etc. Imatinib Mesylate Tablets are contraindicated in people who are allergic to them. The use of Imatinib Mesylate Tablets should be under the guidance of a specialist.